Skip to content
NBDC Human Database

No datasets in the cart.

Go to the cart

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000204

Type of data
NGS (RNA-seq)
Access criteria
Controlled-access (Type I)
Total data volume
76.0 GB
File formats
  • FASTQ
Research
hum0141
Date published
2020-09-28
Date modified
2020-11-18
DDBJ Search
JGAD000204 (opens in a new tab)
JGA Study
JGAS000135 (opens in a new tab)

Analysis method

RNA-seq

Materials and participants
Head and neck cancer: 4cases (15 samples)
HNC1: Malignant neoplasm of supraglottis (ICD10: C32.1)
HNC10: Malignant neoplasm of base of tongue (ICD10: C01)
HNC14: Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx (ICD10: C12)
HNC18: Malignant neoplasm of posterior wall of hypopharynx (ICD10: C13.2)
  • Health status
    Affected
  • Subject count
    15 (Sample)
Disease
Malignant neoplasm of supraglottis (C321)
Malignant neoplasm of base of tongue (C01)
oral cavity and pharynx (C12)
Malignant neoplasm of posterior wall of hypopharynx (C132)
Sample description
RNAs extracted from isolated cells using different markers from tumor tissues of head and neck cancer
- Double Positive (DP): CD25+ CTLA4+ Treg cells
- CD25: CD25+ T cells
- CTLA4: CTLA4+ T cells
- Double Negative (DN): CTLA4- CD25- T cells
  • Tissue
    CD4+ T cell
  • Tumor / normal
    Tumor
Sample provider
N/A
Experimental method
RNA-seq
Target
N/A
Reagent kit
KAPA Library Preparation Kit
Fragmentation
KAPA Frag
Platform
Thermo Fisher Scientific Ion S5
Read type
Single-end
Read length
150 bp (Mean)
Data use policy
NBDC data sharing policy (JGAP000001)